SOMAKIT TOC

This brand name is authorized in Austria, Croatia, Estonia, France, Ireland, Italy, Lithuania, Poland, Spain.

Active ingredients

The drug SOMAKIT TOC contains one active pharmaceutical ingredient (API):

1
UNII U194AS08HZ - EDOTREOTIDE
 

Gallium ⁶⁸Ga edotreotide binds to somatostatin receptors, with highest affinity (Ki = 2.5 ± 0.5 nanomolar) for subtype 2 receptors (sstr2). Gallium ⁶⁸Ga edotreotide binds to cells that express somatostatin receptors including malignant neuroendocrine cells, which overexpress sstr2 receptors.
 
Read more about Gallium ⁶⁸Ga edotreotide

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
V09IX09 V Various → V09 Diagnostic radiopharmaceuticals → V09I Tumour detection → V09IX Other diagnostic radiopharmaceuticals for tumour detection
Discover more medicines within V09IX09

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
EE Ravimiamet 1734645
ES Centro de información online de medicamentos de la AEMPS 1161141001
FR Base de données publique des médicaments 65028549
IT Agenzia del Farmaco 045231014
LT Valstybinė vaistų kontrolės tarnyba 1081824
PL Rejestru Produktów Leczniczych 100381890

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈